Literature DB >> 2770283

A method for hepatic arterial perfusion studies in the rat.

T T Than1, J V Sitzmann, S S Li, P W Lin, L B Grochow.   

Abstract

The current model for selective hepatic arterial infusion therapy was evaluated for its suitability for short-term pharmacokinetic experiments. This preparation consists of selective cannulation of the common hepatic artery via the gastroduodenal artery of the rat. Radioactive microspheres were injected to determine hepatic or extrahepatic sites of perfusion. Radioactive microsphere determination of hepatic arterial flow and cardiac output were also performed. Our data indicate that at high flow rates (2 ml/min), significant loss of drug would occur due to retrograde flow. Modification of the model to include temporary proximal hepatic artery occlusion ensures hepatic delivery of greater than 95% of drug. Furthermore, temporary hepatic artery occlusion does not alter cardiac output or hepatic arterial blood flow. Selective hepatic arterial infusion in rats with synchronous temporary hepatic artery occlusion is an adequate model for short-term pharmacokinetic studies.

Entities:  

Mesh:

Year:  1989        PMID: 2770283     DOI: 10.1016/0022-4804(89)90116-9

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  Pharmacokinetics of regional angiotensin-II: a novel biologic response modifier.

Authors:  Y Wu; J V Sitzmann
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

2.  Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer.

Authors:  Y Wu; P A Cahill; J V Sitzmann
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

3.  An implanted port-catheter system for repeated hepatic arterial infusion of low-density lipoprotein-docosahexaenoic acid nanoparticles in normal rats: A safety study.

Authors:  Yuzhu Wang; Junjie Li; Indhumathy Subramaniyan; Goncalo Dias do Vale; Jaideep Chaudhary; Arnida Anwar; Mary Wight-Carter; Jeffrey G McDonald; William C Putnam; Tao Qin; Hongwei Zhang; Ian R Corbin
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-15       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.